Skip to main content
WeightCited

5-HTP per Appetite Control

C Evidenze Evidenza limitata da studi di piccole dimensioni, ma esistono alcuni segnali positivi.

Double-blind RCT (n=20) found 750 mg/day reduced caloric intake by 38% and produced greater weight loss (1.5 kg vs. +0.2 kg placebo) over 5 weeks. A 12-week crossover trial confirmed reduced carbohydrate and fat intake at 900 mg/day. Sample sizes are small but findings are mechanistically consistent.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'weightcited.com'; const params = 'ingredient\u003D5\u002Dhtp\u0026condition\u003Dappetite\u002Dcontrol'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

In sintesi

Double-blind RCT (n=20) found 750 mg/day reduced caloric intake by 38% and produced greater weight loss (1.5 kg vs. +0.2 kg placebo) over 5 weeks. A 12-week crossover trial confirmed reduced carbohydrate and fat intake at 900 mg/day. Sample sizes are small but findings are mechanistically consistent.

Key Study Findings

Animal Study
Promotion of sleep by cinnamic acid in parachlorophenylalanine-induced insomnia in rats.
Dose: Cinnamic acid (CA) administered to rats (dose not specified) vs: Placebo Effetto: None None
In Vitro
Enhanced production of 5-hydroxytryptophan through the regulation of L-tryptophan biosynthetic pathway.
Dose: recombinant E. coli strain for 5-HTP biosynthesis (engineered pathway) vs: Placebo Effetto: 5-HTP production increased to 1.61 g/L (24% improvement); residual L-trp reduced from 1.66 to 0.2 g/ None
In Vitro
Engineering bacterial phenylalanine 4-hydroxylase for microbial synthesis of human neurotransmitter precursor 5-hydroxytryptophan.
Dose: engineered phenylalanine 4-hydroxylase in E. coli; whole-cell bioconversion from tryptophan vs: Placebo Effetto: 1.1-1.2 g/L 5-HTP production from tryptophan in shake flasks
Observational Study
Both stimulatory and inhibitory effects of dietary 5-hydroxytryptophan and tyrosine are found on urinary excretion …
Dose: 5-hydroxytryptophan (5-HTP) and tyrosine (dietary administration, various doses) vs: Placebo Effetto: 5-HTP showed marginal stimulatory influence on urinary serotonin; tyrosine primarily yielded unexpec None

Key Statistics

4

Studi

100

Partecipanti

Positive

C

Grado

Referenced Papers

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosaggi di uso comune

general:
50-100 mg 1-3x/day
starting:
50 mg/day and titrate up
appetitecontrol:
250-300 mg/day 30 min before meals

Limite massimo: 500 mg/day; avoid combining with SSRIs, SNRIs, MAOIs, or triptans (serotonin syndrome risk)

Dosaggi studiati nella ricerca

Dosaggio Durata Effetto N
Cinnamic acid (CA) administered to rats (dose not specified) -- Positive --
recombinant E. coli strain for 5-HTP biosynthesis (engineered pathway) -- Positive --
engineered phenylalanine 4-hydroxylase in E. coli; whole-cell bioconversion from tryptophan -- Positive --
5-hydroxytryptophan (5-HTP) and tyrosine (dietary administration, various doses) -- Mixed --

Momento migliore per l'assunzione: 30 minutes before meals on an empty stomach

Safety & Side Effects

Effetti collaterali segnalati

  • Nausea
  • Drowsiness
  • GI discomfort
  • Serotonin syndrome risk with contraindicated medications

Interazioni note

  • SSRIs (serotonin syndrome risk — NEVER combine)
  • SNRIs (serotonin syndrome risk — NEVER combine)
  • MAOIs (serotonin syndrome risk — NEVER combine)
  • Triptans (serotonin syndrome risk)
  • Carbidopa

Livello di assunzione massimo tollerabile: 500 mg/day; avoid combining with SSRIs, SNRIs, MAOIs, or triptans (serotonin syndrome risk)

Consultare sempre il proprio medico prima di iniziare qualsiasi integratore.Consultate sempre il vostro medico prima di iniziare qualsiasi integratore.

Frequently Asked Questions

Does 5-HTP help with Appetite Control?
Based on 4 studies with 100 participants, there is limited but promising evidence that 5-HTP may support Appetite Control management. Our evidence grade is C (Some Evidence).
How much 5-HTP should I take for Appetite Control?
Studies have used various dosages. A commonly studied range is 50-100 mg 1-3x/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of 5-HTP?
Reported side effects may include Nausea, Drowsiness, GI discomfort, Serotonin syndrome risk with contraindicated medications. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for 5-HTP and Appetite Control?
We rate the evidence as Grade C (Some Evidence). This rating is based on 4 peer-reviewed studies with 100 total participants. The overall direction of effect is positive.

5-HTP per altre condizioni

References

  1. [1] Xiaona Ye et al.. Int Immunopharmacol. 2025. Promotion of sleep by cinnamic acid in parachlorophenylalanine-induced insomnia in rats. doi:10.1016/j.intimp.2025.114852 PubMed
  2. [2] Da Xu et al.. Appl Microbiol Biotechnol. 2020. Enhanced production of 5-hydroxytryptophan through the regulation of L-tryptophan biosynthetic pathway. doi:10.1007/s00253-020-10371-y PubMed
  3. [3] Yuheng Lin et al.. ACS Synth Biol. 2014. Engineering bacterial phenylalanine 4-hydroxylase for microbial synthesis of human neurotransmitter precursor 5-hydroxytryptophan. doi:10.1021/sb5002505 PubMed
  4. [4] George J Trachte et al.. Neuropsychiatr Dis Treat. 2009. Both stimulatory and inhibitory effects of dietary 5-hydroxytryptophan and tyrosine are found on urinary excretion of serotonin and dopamine in … doi:10.2147/ndt.s5040 PubMed
  5. [5] T C Birdsall. Altern Med Rev. 1998. 5-Hydroxytryptophan: a clinically-effective serotonin precursor. PubMed

Avvertenza FDA: Queste affermazioni non sono state valutate dalla Food and Drug Administration. I prodotti e le informazioni presenti su questo sito web non sono destinati a diagnosticare, trattare, curare o prevenire alcuna malattia. I gradi di evidenza presentati si basano sulla nostra analisi della ricerca pubblicata e sottoposta a revisione paritaria e non costituiscono consulenza medica. Consultate sempre il vostro medico prima di iniziare qualsiasi regime di integrazione.